Here is Oppenheimer's top buy and sell stock ideas within each sector via SeekingAlpha - Within Technology: Buy Apple $AAPL, Sell Fair Isaac Corporation $FICO - Within Communication Services: Buy Google $GOOG, Sell Walt Disney $DIS - Within Consumer Discretionary: Buy Amazon $AMZN, Sell Home Depot $HD - Within Energy: Buy Targa Resources $TRGP, Sell EQT Corporation $EQT - Within Materials: Buy Corteva $CTVA, Sell International Paper $IP - Within Industrials: Buy W.W. Grainger $GWW, Sell Uber Technologies $UBER - Within Consumer Staples: Buy Archer-Daniels-Midland $ADM, Sell PepsiCo $PEP - Within Healthcare: Buy Neurocrine Biosciences $NBIX, Sell Danaher Corporation $DHR - Within Financials: Buy JPMorgan Chase $JPM, Sell Jack Henry & Associates $JKHY - Within REITs: Buy Welltower $WELL, Sell Crown Castle $CCI - Within Utilities: Buy Entergy $ETR, Sell Constellation Energy $CEG

🎬 'Michael' has dethroned Oppenheimer The Michael Jackson biopic has grossed $977 million worldwide, becoming the highest-grossing biographical film of all time and surpassing Oppenheimer. The film is now closing in on the $1 billion milestone.

odyssey review: - it is basically just oppenheimer with swords - the casting is bad - agamemnon has tremendous aura. they should give him a solo film - anne hatheway solo carries - the theme about civilizational rules is well done - overall: not good, not bad. just mid

🫡 Palantir heads into earnings TODAY Oppenheimer just slapped a $200 price target. That´s a 40% upside from current $PLTR levels. - Rev seen $1.54B (+70%+ YoY) - EPS expected to more than double Big growth is priced in. Now it’s about delivery.

Join me and visionary thinker and investor Eric Larsen, president of TowerBrook Advisors to discuss the idea behind Eric's latest essay, Healthcare's Oppenheimer Moment: AI is the industrialization of intelligence, and healthcare — expensive, labor-heavy, and sitting on decades of dormant data — is ground zero for what happens next. Watch me pressure-test his healthcare-AI thesis in real-time. Just some of what we'll get into: • Why Eric calls revenue cycle the coding of healthcare labor automation. • How to map AI exposure by task, not job title. • Who will be the real winners in the bot war? • Where and how Eric puts his own conviction on the line. • Why a single EHR instance is table stakes, not a revenue cycle strategy. Free - register now! @TowerBrook @Hospitalogy_HC

Higher inflation and interest rates, rising government debt, and geopolitical fragmentation have helped enable a new investing regime that could favor capital-intensive companies, according to Peter Oppenheimer, chief global equity strategist in Goldman Sachs Research. Read more:

Christopher Nolan’s “The Odyssey” launched with an estimated $124.5 million in domestic ticket sales and another $139.6 million from overseas, notching a bigger debut than “Oppenheimer” and marking his best opening since 2012’s “The Dark Knight Rises.”